These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29635808)

  • 1. Cancer drug shortages: Awareness and perspectives from a representative sample of the US population.
    Frosch ZAK; Cronin AM; Gagne JJ; Teschke MP; Gray SW; Abel GA
    Cancer; 2018 May; 124(10):2205-2211. PubMed ID: 29635808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Qualitative Analysis of Oncology Patient Awareness of Medication Shortages and Their Preferences for How Shortages Should Be Managed.
    Hantel A; Hlubocky FJ; Siegler M; Daugherty CK
    JCO Oncol Pract; 2020 Oct; 16(10):e1098-e1111. PubMed ID: 32469685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the opinions and experiences of patients with generic substitution: a representative study of Polish society.
    Drozdowska A; Hermanowski T
    Int J Clin Pharm; 2015 Feb; 37(1):68-75. PubMed ID: 25428446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Framework for tackling paediatric chemotherapy drug shortages.
    Tanday S
    Lancet Oncol; 2016 Mar; 17(3):e93. PubMed ID: 26831287
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug shortages delay cancer clinical trials.
    Goozner M
    J Natl Cancer Inst; 2012 Jun; 104(12):891-2. PubMed ID: 22715189
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of shortages of injectable oncology drugs on patient care.
    Goldsack JC; Reilly C; Bush C; McElligott S; Bristol MN; Motanya UN; Field R; Vozniak JM; Wong YN; Schwartz JS; Domchek S
    Am J Health Syst Pharm; 2014 Apr; 71(7):571-8. PubMed ID: 24644117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy drug shortages in paediatric oncology: A 14-year single-centre experience in Belgium.
    Bauters T; Claus BO; Norga K; Huys I; Simoens S; Laureys G
    J Oncol Pharm Pract; 2016 Dec; 22(6):766-770. PubMed ID: 26447099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring factors underlying the attitude of community pharmacists to generic substitution: a nationwide study from Poland.
    Drozdowska A; Hermanowski T
    Int J Clin Pharm; 2016 Feb; 38(1):162-70. PubMed ID: 26620450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of oncology drug shortages on patient therapy: unplanned treatment changes.
    Becker DJ; Talwar S; Levy BP; Thorn M; Roitman J; Blum RH; Harrison LB; Grossbard ML
    J Oncol Pract; 2013 Jul; 9(4):e122-8. PubMed ID: 23942928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National survey on the effect of oncology drug shortages on cancer care.
    McBride A; Holle LM; Westendorf C; Sidebottom M; Griffith N; Muller RJ; Hoffman JM
    Am J Health Syst Pharm; 2013 Apr; 70(7):609-17. PubMed ID: 23515514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Religious hospital policies on reproductive care: what do patients want to know?
    Freedman LR; Hebert LE; Battistelli MF; Stulberg DB
    Am J Obstet Gynecol; 2018 Feb; 218(2):251.e1-251.e9. PubMed ID: 29221943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of chemotherapy shortages on COG and local clinical trials: a report from the Children's Oncology Group.
    G Salazar E; Bernhardt MB; Li Y; Aplenc R; Adamson PC
    Pediatr Blood Cancer; 2015 Jun; 62(6):940-4. PubMed ID: 25704486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of drug shortages on children with cancer--the example of mechlorethamine.
    Metzger ML; Billett A; Link MP
    N Engl J Med; 2012 Dec; 367(26):2461-3. PubMed ID: 23268661
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemotherapy and Supportive Care Agents as Essential Medicines for Children With Cancer.
    Unguru Y; Bernhardt MB; Berg SL; Johnson LM; Pyke-Grimm K; Woodman C; Fernandez CV
    JAMA Pediatr; 2019 May; 173(5):477-484. PubMed ID: 30830204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug shortages: Implications for medical toxicology.
    Mazer-Amirshahi M; Hawley KL; Zocchi M; Fox E; Pines JM; Nelson LS
    Clin Toxicol (Phila); 2015 Jul; 53(6):519-24. PubMed ID: 25951876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generic medications for you, but brand-name medications for me.
    Keenum AJ; Devoe JE; Chisolm DJ; Wallace LS
    Res Social Adm Pharm; 2012; 8(6):574-8. PubMed ID: 22357268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients perspectives on drug shortages in six European hospital settings - a cross sectional study.
    Kuruc Poje D; Kifer D; Huys I; Miranda J; Jenzer H; Miljković N; Hoppe-Tichy T; Bochniarz M; Frontini R; Schwartz DG; Vujić-Aleksić V; Nežić L; Rinaki E; Tzimis L; Green K; Jovanić J; Carić B; Mandić D; Vilić K; Bochenek T; Bačić Vrca V; Marušić S
    BMC Health Serv Res; 2021 Jul; 21(1):689. PubMed ID: 34253212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical drug shortages: implications for emergency medicine.
    Mazer-Amirshahi M; Pourmand A; Singer S; Pines JM; van den Anker J
    Acad Emerg Med; 2014 Jun; 21(6):704-11. PubMed ID: 25039558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethical considerations for the clinical oncologist in an era of oncology drug shortages.
    Jagsi R; Spence R; Rathmell WK; Bradbury A; Peppercorn J; Grubbs S; Moy B
    Oncologist; 2014 Feb; 19(2):186-92. PubMed ID: 24449096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient and public attitudes towards informed consent models and levels of awareness of Electronic Health Records in the UK.
    Riordan F; Papoutsi C; Reed JE; Marston C; Bell D; Majeed A
    Int J Med Inform; 2015 Apr; 84(4):237-47. PubMed ID: 25649841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.